Christopher v. Smithkline Beecham Corp.

2012-06-18

Headline: Court rules pharmaceutical drug detailers are 'outside salesmen' under Labor Department rules, letting companies avoid paying overtime to these sales representatives nationwide.

Holding: The Court ruled that pharmaceutical sales representatives who obtain nonbinding commitments from physicians are 'outside salesmen' under Labor Department regulations and are therefore exempt from the FLSA’s overtime requirement.

Real World Impact:

Allows drug companies to classify pharmaceutical detailers as exempt from overtime pay.
Affects roughly 90,000 pharmaceutical sales representatives nationwide.
Limits the Labor Department’s ability to impose retroactive liability from new interpretations.

Topics: pharmaceutical sales, overtime pay, employee classification, labor department rules, agency interpretation

Summary

Background

The case involves two pharmaceutical sales representatives who worked for a drug company and sued for unpaid overtime under the Fair Labor Standards Act. Their job was to visit physicians, provide product information, and secure nonbinding commitments from doctors to prescribe the company’s drugs when appropriate. The company did not pay time-and-a-half for hours over 40. The District Court granted summary judgment for the company, the Ninth Circuit affirmed, and the Supreme Court agreed to resolve a split with another circuit.

Reasoning

The central question was whether the workers’ primary duty—obtaining nonbinding commitments from physicians—counts as “making sales” under the statute and Department of Labor regulations. The Court declined to give the Department of Labor’s newer briefs controlling deference and instead reviewed the statute and regulations directly. It concluded that the statutory definition of “sale” (which includes a broad catchall phrase, “other disposition”) and the industry’s regulatory context reasonably encompass the detailers’ work. The Court emphasized the workers’ sales-like duties, incentives, field work, and limited supervision, and found that a physician’s nonbinding commitment fits the regulatory language in this heavily regulated industry.

Real world impact

The Court affirmed that these pharmaceutical detailers qualify as exempt outside salesmen, so employers need not pay overtime under the FLSA for similar work. The decision affects how drug companies classify detailers, and it limits the Department of Labor’s ability to impose liability based on its later, contrary interpretations.

Dissents or concurrances

The dissent argued detailers do not make sales because they do not transfer title, consummate sales, or obtain firm commitments and instead perform promotional, informational work directed at sales made by others.